Free press releases distribution network?

Agency / Source: rfXcel Corporation

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



rfXcel Announces Availability of Timeline Analyzer for ePedigree and Serialization Implementation - Pharmaceutical industry's most Production-proven E-Pedigree Solution provider offers planning tool for ePedigree and serialization compliance scheduling
rfXcel Announces Availability of Timeline Analyzer for ePedigree and Serialization Implementation

 

PRZOOM - /newswire/ - San Ramon, CA, United States, 2008/06/30 - Pharmaceutical industry's most Production-proven E-Pedigree Solution provider offers planning tool for ePedigree and serialization compliance scheduling.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

rfXcel Corporation, the leading provider of production-proven ePedigree Management solutions that allow manufacturers, distributors, and retailers to track the chain of custody of prescription drugs through the pharmaceutical supply chain, today announced the availability of a Timeline Analysis tool to help in planning out an implementation timeline for California ePedigree and Serialization compliance.

California’s decision to delay the compliance requirement to its electronic pedigree law until January 1, 2011 has provided more time for pharmaceutical companies to complete their implementations. However, with the strict resource and timeline requirements that Pedigree and Serialization implementation place on an organization, it’s extremely important for companies to start early enough to insure that they are compliant when the deadline comes.

The California Compliance Timeline Analyzer provides an effective tool for all members of the pharmaceutical value chain to develop a plan that’s specific to their own requirements. With individual tabs for manufacturers, wholesalers, and retailers, the tool prompts the user for information such as the number of SKU’s, packaging locations, packaging lines, trading partners, etc. Based on the answers to these and other questions, the tool calculates work estimates for such things as label changes, IT infrastructure design, line/equipment design, direct labor, etc. Finally, it displays a detailed timeline, in the form of a Gantt chart, listing all of the various tasks associated with a trading partner’s specific implementation.

“January 1, 2011 is closer than you think”, said Thomas Pizzuto, VP of Client Services at rfXcel. “Tools like the Compliance Timeline Analyzer will provide valuable insight into the work scope necessary so that you can effectively mobilize at the right time to insure completion by the deadline”.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: rfXcel Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


rfXcel Announces Availability of Timeline Analyzer for ePedigree and Serialization Implementation

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Jim Ensell - rfXcel.com 
925-325-0584 jensell[.]rfxcel.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any rfXcel Corporation securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From rfXcel Corporation / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
Ipsen Announces MHRA Approval of New Indication for Decapeptyl® for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  BizJobs.com

Visit  JobsWare.com







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today